BioViva Science to Begin Series A Raise in 2023
BioViva's 2022 research has yielded new discoveries in gene therapy delivery and enhancing healthy longevity. SEATTLE, Nov. 11, 2022 /PRNewswire/ -- Founded to address biological aging with gene therapy, BioViva Sciences is broadening its horizons. …